comparemela.com

Latest Breaking News On - Pharmaceuticals company profile - Page 12 : comparemela.com

ARS Pharmaceuticals, Inc (NASDAQ:SPRY) Insider Sells $21,133 86 in Stock

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 2,343 shares of the stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $9.02, for a total value of $21,133.86. Following the completion of the transaction, the insider now owns 1,745,082 shares of the company’s […]

Stephen Davis Sells 17,714 Shares of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Stock

Stephen Davis Sells 17,714 Shares of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Short Interest in China SXT Pharmaceuticals, Inc (NASDAQ:SXTC) Decreases By 93 4%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 5,500 shares, a decline of 93.4% from the February 29th total of 82,800 shares. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is […]

Insider Selling: ARS Pharmaceuticals, Inc (NASDAQ:SPRY) Insider Sells 2,343 Shares of Stock

Insider Selling: ARS Pharmaceuticals, Inc (NASDAQ:SPRY) Insider Sells 2,343 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

CASI Pharmaceuticals, Inc (NASDAQ:CASI) Short Interest Update

CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 127,300 shares, a growth of 204.5% from the February 29th total of 41,800 shares. Currently, 2.2% of the shares of the company are short sold. Based on an average […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.